Literature DB >> 36258147

Enantiopure β-isocyano-boronic esters: synthesis and exploitation in isocyanide-based multicomponent reactions.

Marco Manenti1, Simone Gusmini1, Leonardo Lo Presti1, Giorgio Molteni1, Alessandra Silvani2.   

Abstract

Various boron-containing isocyanides have been efficiently synthesized from the corresponding enantiopure β-substituted β-amino boronic acid pinacol esters, without need for protecting group interconversion, through a two-step, purification-free procedure. They were employed in a variety of isocyanide-based multicomponent reactions, proving to be reliable components for all of them and allowing the efficient synthesis of unprecedented, boron-containing peptidomimetics and heteroatom-rich small molecules, including biologically relevant cyclic boronates. Jointing together the β-amido boronic acid moiety, deriving from the isocyanide component, with prominent pharmacophoric rings emerging from the multicomponent process, a successful application of the molecular hybridization concept could be realized.
© 2022. The Author(s).

Entities:  

Keywords:  Boronic acids; Heterocycles; Isocyanides; Multicomponent reactions; Peptidomimetics

Year:  2022        PMID: 36258147     DOI: 10.1007/s11030-022-10549-8

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   3.364


  28 in total

Review 1.  Chemistry and biology of multicomponent reactions.

Authors:  Alexander Dömling; Wei Wang; Kan Wang
Journal:  Chem Rev       Date:  2012-03-22       Impact factor: 60.622

2.  ZnO-nanorods Promoted Synthesis of α-amino Nitrile Benzofuran Derivatives using One-pot Multicomponent Reaction of Isocyanides.

Authors:  Asef H Najar; Zinatossadat Hossaini; Shahrzad Abdolmohammadi; Daryoush Zareyee
Journal:  Comb Chem High Throughput Screen       Date:  2020       Impact factor: 1.339

3.  Isocyanide Multicomponent Reactions on Solid-Phase-Coupled DNA Oligonucleotides for Encoded Library Synthesis.

Authors:  Verena B K Kunig; Christiane Ehrt; Alexander Dömling; Andreas Brunschweiger
Journal:  Org Lett       Date:  2019-08-29       Impact factor: 6.005

4.  Total synthesis of exigurin: the Ugi reaction in a hypothetical biosynthesis of natural products.

Authors:  Seijiro Hosokawa; Keisuke Nakanishi; Yutaro Udagawa; Mitsutoshi Maeda; Seiya Sato; Keiji Nakano; Toshiya Masuda; Yoshiyasu Ichikawa
Journal:  Org Biomol Chem       Date:  2020-01-06       Impact factor: 3.876

5.  Sequential Multicomponent Strategy for the Diastereoselective Synthesis of Densely Functionalized Spirooxindole-Fused Thiazolidines.

Authors:  Giulia Rainoldi; Fabio Begnini; Mariska de Munnik; Leonardo Lo Presti; Christophe M L Vande Velde; Romano Orru; Giordano Lesma; Eelco Ruijter; Alessandra Silvani
Journal:  ACS Comb Sci       Date:  2018-01-25       Impact factor: 3.784

6.  Introducing multicomponent reactions to polymer science: Passerini reactions of renewable monomers.

Authors:  Oliver Kreye; Tommy Tóth; Michael A R Meier
Journal:  J Am Chem Soc       Date:  2011-01-25       Impact factor: 15.419

Review 7.  Catalytic Enantioselective Isocyanide-Based Reactions: Beyond Passerini and Ugi Multicomponent Reactions.

Authors:  Jian Luo; Guo-Shu Chen; Shu-Jie Chen; Zhao-Dong Li; Yun-Lin Liu
Journal:  Chemistry       Date:  2021-03-05       Impact factor: 5.236

Review 8.  Two decades of recent advances of Ugi reactions: synthetic and pharmaceutical applications.

Authors:  Manar Ahmed Fouad; Hamida Abdel-Hamid; Mohammed Salah Ayoup
Journal:  RSC Adv       Date:  2020-11-23       Impact factor: 4.036

Review 9.  Isocyanide-based multicomponent reactions towards cyclic constrained peptidomimetics.

Authors:  Gijs Koopmanschap; Eelco Ruijter; Romano Va Orru
Journal:  Beilstein J Org Chem       Date:  2014-03-04       Impact factor: 2.883

10.  One step access to oxindole-based β-lactams through Ugi four-center three-component reaction.

Authors:  Giulia Rainoldi; Giordano Lesma; Claudia Picozzi; Leonardo Lo Presti; Alessandra Silvani
Journal:  RSC Adv       Date:  2018-10-11       Impact factor: 4.036

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.